cls,trl_lbl,data_lvl,trials,n,m,s,q05,q95
A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,agg,5,48377,65.11141163231581,8.601316687149872,51.32421072094177,79.52360476972947
A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,ipd,1,5384,60.80492918429589,9.88187930853157,44.58712430589032,77.16228344611956
A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,agg,8,54773,63.52472255653801,8.376894907760459,49.801633721490376,77.12480478254376
A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,ipd,1,9461,64.03170825346866,8.710973368966977,49.670660250233844,78.28441515915856
A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,agg,5,37377,65.42001223939671,7.94341600302498,52.725073975230195,78.87996164074586
A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,ipd,4,21608,61.08549082935043,9.029813070145728,45,75.50348929663235
Any,Total trials,agg,18,140527,64.57505096243234,8.385723626707923,51.02533961612491,78.52948472863369
Any,Total trials,ipd,6,36453,61.808713037470724,9.175302827975122,45,76.71934807760135
